Is pelvic prophylactic radiotherapy in prostate cancer just right?
作者信息
Taussky Daniel, Delouya Guila
机构信息
Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal (CHUM), Canada.
出版信息
Transl Androl Urol. 2020 Oct;9(5):2296-2298. doi: 10.21037/tau-20-881.
Abstract
摘要
相似文献
1
Is pelvic prophylactic radiotherapy in prostate cancer just right?前列腺癌的盆腔预防性放射治疗是否恰到好处？
Transl Androl Urol. 2020 Oct;9(5):2296-2298. doi: 10.21037/tau-20-881.
2
[Prophylactic nodal radiotherapy in prostate cancer].
Cancer Radiother. 2019 Oct;23(6-7):688-695. doi: 10.1016/j.canrad.2019.07.149. Epub 2019 Aug 23.
3
Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.前列腺癌放射治疗后的盆腔并发症及其处理：国际协作叙事性综述。
Eur Urol. 2019 Mar;75(3):464-476. doi: 10.1016/j.eururo.2018.12.003. Epub 2018 Dec 17.
4
Early Results of Extreme Hypofractionation Using Stereotactic Body Radiation Therapy for High-risk, Very High-risk and Node-positive Prostate Cancer.立体定向体部放射治疗高危、极高危和淋巴结阳性前列腺癌的超分割早期结果。
Clin Oncol (R Coll Radiol). 2018 Jul;30(7):442-447. doi: 10.1016/j.clon.2018.03.004. Epub 2018 Mar 21.
5
A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.一项关于使用基准标记进行图像引导调强放疗治疗包括盆腔淋巴结在内的局限性前列腺癌的研究。
Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):898-902. doi: 10.1016/j.ijrobp.2007.02.030. Epub 2007 Apr 24.
6
Does pelvic irradiation play a role in the management of prostate cancer?
Oncology (Williston Park). 1998 Oct;12(10):1467-72; discussion 1472, 1475-6.
7
CT Simulation to Evaluate of Pelvic Lymph Node Coverage in Conventional Radiotherapy Fields Based on Bone and Vessels Landmarks in Prostate Cancer Patients.基于前列腺癌患者骨骼和血管标志物的CT模拟评估常规放疗野中盆腔淋巴结覆盖情况
Iran J Cancer Prev. 2016 Jun 14;9(3):e6233. doi: 10.17795/ijcp-6233. eCollection 2016 Jun.
8
PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost.初始盆腔淋巴结调强放疗和前列腺质子推量治疗前列腺癌患者的 PTV 边界分析。
Phys Med Biol. 2019 Feb 8;64(4):04NT04. doi: 10.1088/1361-6560/aafd75.
9
Prophylactic Extended-Field Irradiation in Patients With Cervical Cancer: A Literature Review.宫颈癌患者的预防性扩大野照射：文献综述
Front Oncol. 2020 Oct 2;10:579410. doi: 10.3389/fonc.2020.579410. eCollection 2020.
10
Target repositioning optimization in prostate cancer: is intensity-modulated radiotherapy under stereotactic conditions feasible?前列腺癌中的靶点重新定位优化：立体定向条件下的调强放射治疗是否可行？
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):366-71. doi: 10.1016/j.ijrobp.2003.10.012.
引用本文的文献
1
Assessing radiation dose for postoperative radiotherapy in prostate cancer: Real world data.评估前列腺癌术后放疗的辐射剂量：真实世界数据。
World J Clin Oncol. 2022 Jul 24;13(7):652-662. doi: 10.5306/wjco.v13.i7.652.
2
Pelvic nodal radiotherapy in Gleason grade group 5 prostate cancer.Gleason 5级前列腺癌的盆腔淋巴结放疗
Transl Androl Urol. 2020 Oct;9(5):2326-2328. doi: 10.21037/tau-20-917.
本文引用的文献
1
Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer.局部前列腺癌常规分割与适度超分割放射治疗的前瞻性随机试验十年更新。
J Clin Oncol. 2020 May 20;38(15):1676-1684. doi: 10.1200/JCO.19.01485. Epub 2020 Mar 2.
2
Shifting the Curtain-Can We Make Sense of the Whole Pelvis Controversy?
Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):534-536. doi: 10.1016/j.ijrobp.2019.11.012.
3
PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review.PSMA PET 用于中高危前列腺癌的初级淋巴结分期：快速系统评价。
Cancer Imaging. 2020 Jan 23;20(1):10. doi: 10.1186/s40644-020-0290-9.
4
External Beam Radiation Therapy (EBRT) and High-Dose-Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume.外照射放射治疗（EBRT）和高剂量率（HDR）近距离放射治疗中高危前列腺癌：EBRT 体积的影响。
Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):525-533. doi: 10.1016/j.ijrobp.2019.09.044. Epub 2019 Oct 11.
5
Randomized Trials and the Goldilocks Problem.
Eur Urol. 2020 Jan;77(1):11-13. doi: 10.1016/j.eururo.2019.05.002. Epub 2019 May 16.
6
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.仅前列腺放疗与全骨盆放疗联合或不联合近距离放疗治疗格里森 5 分组前列腺癌的回顾性分析。
Eur Urol. 2020 Jan;77(1):3-10. doi: 10.1016/j.eururo.2019.03.022. Epub 2019 Apr 13.
7
Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL).在晚期局限性前列腺癌中，前列腺和盆腔淋巴结与仅前列腺放射治疗的 2 期随机试验的毒性和患者报告结局（PIVOTAL）。
Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):605-617. doi: 10.1016/j.ijrobp.2018.10.003. Epub 2018 Dec 6.
8
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.激素治疗与放疗靶区大小在局部进展性前列腺癌中的研究（NRG/RTOG9413）：一项随机、3 期临床试验的长期结果。
Lancet Oncol. 2018 Nov;19(11):1504-1515. doi: 10.1016/S1470-2045(18)30528-X. Epub 2018 Oct 10.
9
The 46th David A. Karnofsky Memorial Award Lecture: Oligometastasis-From Conception to Treatment.第46届大卫·A·卡诺夫斯基纪念奖讲座：寡转移——从概念到治疗
J Clin Oncol. 2018 Nov 10;36(32):3240-3250. doi: 10.1200/JCO.18.00847. Epub 2018 Sep 27.
10
Potential Impact of Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.镓-PSMA-11 PET/CT 对前列腺癌根治性放疗计划的潜在影响。
J Nucl Med. 2018 Nov;59(11):1714-1721. doi: 10.2967/jnumed.118.209387. Epub 2018 Apr 13.
Zotero 插件